Bioorganic and Medicinal Chemistry p. 3500 - 3511 (2017)
Update date:2022-08-02
Topics:
Guo, Jing
Zhu, Mingyue
Wu, Tianxiao
Hao, Chenzhou
Wang, Kai
Yan, Zizheng
Huang, Wanxu
Wang, Jian
Zhao, Dongmei
Cheng, Maosheng
Utilizing a pharmacophore hybridization approach, a novel series of substituted indolin-2-one derivatives were designed, synthesized and evaluated for their in vitro biological activities against p21-activated kinase 4. Compounds 11b, 12d and 12g exhibited the most potent inhibitory activity against PAK4 (IC50?=?22?nM, 16?nM and 27?nM, respectively). Among them, compound 12g showed the highest antiproliferative activity against A549 cells (IC50?=?0.83?μM). Apoptosis analysis in A549 cells suggested that compound 12g delayed cell cycle progression by arresting cells in the G2/M phase of the cell cycle, retarding cell growth. Further investigation demonstrated that compound 12g strongly inhibited migration and invasion of A549 cells. Western blot analysis indicated that compound 12g potently inhibited the PAK4/LIMK1/cofilin signalling pathways. Finally, the binding mode between compound 12g with PAK4 was proposed by molecular docking. A preliminary ADME profile of the compound 12g was also drawn on the basis of QikProp predictions.
View MoreTaizhou YOJOY Chemical Co., Ltd.
Contact:13857143241
Address:Yangfu Industrial Park, Xianju, Zhejiang, P. R. China
Xiamen Goodhealth Pharmchem Co., Ltd.
Contact:0086-592-2097683
Address:404R No.2 54# Minzu Rd., Xiamen, China
shandong lukang animal & plant drug trading co.,ltd.
Contact:15853765968
Address:floor 9, lukang ,jingying building,#173,taibai building west road,jining city,shandong,china
Changzhou Anyi Biochem Co., Ltd.(expird)
Contact:+86-519-88836158
Address:no,51 caoda
Leshan Kai Yada Photoelectric Technology Co., Ltd.,
website:http://www.kydmaterials.com
Contact:0833-5603116
Address:Airport road Jiajiang county, Sichuan province,China
Doi:10.1016/j.tet.2009.02.075
(2009)Doi:10.1007/s00706-007-0836-6
(2008)Doi:10.1080/07328300902789209
(2009)Doi:10.1055/s-0028-1083358
(2009)Doi:10.1002/anie.201307535
()Doi:10.1016/S0039-128X(97)00159-1
(1998)